1. What role does multiple sclerosis play in the development of untreatable painful conditions?
    Stefania Ceruti, 2017, Pain Management CrossRef
  2. The role of TGF-β superfamily signaling in neurological disorders
    Risa Kashima et al, 2017 CrossRef
  3. Relationship of Fatigue to Heat Sensitivity in Patients With Multiple Sclerosis: A Review for Management
    Pamela Newland et al, 2018, The Journal for Nurse Practitioners CrossRef
  4. RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis
    Alba Manresa-Arraut et al, 2018, Front. Immunol. CrossRef
  5. There is no benefit in the use of postnatal intravenous immunoglobulin for the prevention of relapses of multiple sclerosis: findings from a systematic review and meta-analysis
    Gleysson Rodrigues Rosa et al, 2018, Arq. Neuro-Psiquiatr. CrossRef
  6. Vitamin D role in multiple sclerosis etiology and therapy
    Sunčica Stankov et al, 2018, Medicinski časopis CrossRef
  7. Temperature sensitivity in multiple sclerosis: An overview of its impact on sensory and cognitive symptoms
    Aikaterini Christogianni et al, 2018, Temperature CrossRef
  8. Impact of pre-cooling therapy on the physical performance and functional capacity of multiple sclerosis patients: A systematic review
    Antonia Kaltsatou et al, 2018, Multiple Sclerosis and Related Disorders CrossRef
  9. Acceptance of mHealth Apps for Disease-Management among People with Multiple Sclerosis: Web-based Survey Study (Preprint)
    Jennifer Apolinário-Hagen et al, 2018 CrossRef
  10. Headache in Multiple Sclerosis From a Different Perspective: A Prospective Study
    Gökhan Özer et al, 2018, J Clin Exp Invest CrossRef
  11. Oxysterols as a biomarker in diseases
    Adam Zmysłowski et al, 2019, Clinica Chimica Acta CrossRef
  12. Bowel symptoms predate the diagnosis among many patients with multiple sclerosis: A 14‐year cohort study
    Mariana N. Almeida et al, 2019, Neurogastroenterology & Motility CrossRef
  13. Altered expression patterns of complement factor H and miR‐146a genes in acute‐chronic phases in experimental autoimmune encephalomyelitis mouse
    Saba Gharibi et al, 2019, J Cell Physiol CrossRef
  14. null
    Munibah Qureshi et al, 2019 CrossRef
  15. Down-regulation of ERMN expression in relapsing remitting multiple sclerosis
    Behnaz Salek Esfahani et al, 2019, Metab Brain Dis CrossRef
  16. Early auto‐immune targeting of photoreceptor ribbon synapses in mouse models of multiple sclerosis
    Mayur Dembla et al, 2018, EMBO Mol Med CrossRef
  17. Cannabinoid CB2 Receptor Functional Variation (Q63R) Is Associated with Multiple Sclerosis in Iranian Subjects
    Alireza Tahamtan et al, 2019, J Mol Neurosci CrossRef
  18. Computational Drug Repurposing Algorithm Targeting TRPA1 Calcium Channel as a Potential Therapeutic Solution for Multiple Sclerosis.
    George mihai Nitulescu, 0 CrossRef
  19. Artemisia dracunculus L. modulates the immune system in a multiple sclerosis mouse model
    Hamidreza Safari et al, 2019, Nutritional Neuroscience CrossRef
  20. How the redox state regulates immunity
    Lisa Mullen et al, 2019, Free Radical Biology and Medicine CrossRef
  21. Multiple sclerosis
    Christine A. Varner, 2020, Nursing Made Incredibly Easy! CrossRef
  22. Does CSF pleocytosis have a predictive value for disease course in MS?
    Itay Lotan et al, 2019, Neurol Neuroimmunol Neuroinflamm CrossRef
  23. Application of Artificial Neural Network for Prediction of Risk of Multiple Sclerosis Based on Single Nucleotide Polymorphism Genotypes
    Soudeh Ghafouri-Fard et al, 2020, J Mol Neurosci CrossRef
  24. A Definition of “Multitargeticity”: Identifying Potential Multitarget and Selective Ligands Through a Vector Analysis
    Juan Francisco Sánchez-Tejeda et al, 2020, Front. Chem. CrossRef
  25. Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines
    Masaru Tanaka et al, 2020, IJMS CrossRef
  26. Memory Impairment in Relapsing-Remitting Multiple Sclerosis Using a Challenging Semantic Interference Task
    Jordi A. Matias-Guiu et al, 2020, Front. Neurol. CrossRef
  27. Validity and Reliability Study of the Turkish Version of Multiple Sclerosis Self-Management Scale
    Öznur Erbay et al, 2020, Journal of Neuroscience Nursing CrossRef
  28. In vitro Models of Neurodegenerative Diseases
    Anna Slanzi et al, 2020, Front. Cell Dev. Biol. CrossRef
  29. Molecular Interventions towards Multiple Sclerosis Treatment
    Athanasios Metaxakis et al, 2020, Brain Sciences CrossRef
  30. Umbilical cord-derived mesenchymal stem cells in neurodegenerative disorders: from literature to clinical practice
    Samira Reyhani et al, 2020, Regenerative Medicine CrossRef
  31. Epidemiology of pediatric multiple sclerosis: A systematic literature review and meta-analysis
    Kevin Yan et al, 2020, Multiple Sclerosis and Related Disorders CrossRef
  32. A new paraplegin mutation in a patient with primary progressive multiple sclerosis
    Angelo Bellinvia et al, 2020, Multiple Sclerosis and Related Disorders CrossRef
  33. Methodology to evaluate temperature changes in multiple sclerosis patients by calculating texture features from infrared thermography images
    Sandra Pérez-Buitrago et al, 2020, Quantitative InfraRed Thermography Journal CrossRef
  34. The Role of MicroRNAs in Repair Processes in Multiple Sclerosis
    Conor P. Duffy et al, 2020, Cells CrossRef
  35. The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases through Cannabinoid System Modulation-Evidence from In Vivo Studies.
    Daniela Calina et al, 2020, J Clin Med CrossRef
  36. Evaluation of the Diagnostic and Predictive Value of Serum Levels of ANT1, ATG5, and Parkin in Multiple Sclerosis
    Omid joodi khanghah et al, 2020, Clinical Neurology and Neurosurgery CrossRef
  37. Alterations of peripheral nerve excitability in an experimental autoimmune encephalomyelitis mouse model for multiple sclerosis
    Nathalia Bernardes Teixeira et al, 2020, J Neuroinflammation CrossRef
  38. null
    Parisa Dehghani et al, 2020 CrossRef
  39. Case Report: A case of immune checkpoint inhibitor therapy in a patient with multiple sclerosis
    Raju Vaddepally et al, 2020, F1000Res CrossRef
  40. Beneficial Roles of Microglia and Growth Factors in MS, a Brief Review
    Vincent Pons et al, 2020, Front. Cell. Neurosci. CrossRef
  41. Complement-Mediated Microglial Phagocytosis and Pathological Changes in the Development and Degeneration of the Visual System
    Davis M. Borucki et al, 2020, Front. Immunol. CrossRef
  42. Lesion load assessment among multiple sclerosis patient using DIR, FLAIR, and T2WI sequences
    Abdullah Dhaifallah Almutairi et al, 2020, Egypt J Radiol Nucl Med CrossRef
  43. Quantitative proteomic analysis of cerebrospinal fluid of women newly diagnosed with multiple sclerosis
    Eliska Jankovska et al, 2020, International Journal of Neuroscience CrossRef
  44. null
    Chris W. J. van der Weijden et al, 2021 CrossRef
  45. null
    Fabin Han et al, 2020 CrossRef
  46. Combining Magnetization Transfer Ratio MRI and Quantitative Measures of Walking Improves the Identification of Fallers in MS
    Nora E. Fritz et al, 2020, Brain Sciences CrossRef
  47. Use of Participatory Action Research in the Development of a Survey of Physiotherapy Services for People with Multiple Sclerosis in Canada
    Ayse Kuspinar et al, 2020, Physiotherapy Canada CrossRef
  48. Ozanimod to Treat Relapsing Forms of Multiple Sclerosis: A Comprehensive Review of Disease, Drug Efficacy and Side Effects
    Grace Lassiter et al, 2020, Neurology International CrossRef
  49. The epidemiology of primary headaches in patients with multiple sclerosis
    Long Wang et al, 2020, Brain Behav CrossRef
  50. Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway
    Nóra Török et al, 2020, IJMS CrossRef
  51. Speech Discrimination Tasks: A Sensitive Sensory and Cognitive Measure in Early and Mild Multiple Sclerosis
    Pippa Iva et al, 2020, Front. Neurosci. CrossRef
  52. The Prevalence and Association of Depression and Anxiety With Multiple Sclerosis in Riyadh, Saudi Arabia: A Cross-Sectional Study
    Ali Bahathig et al, 2020 CrossRef
  53. An interdependence between GAPVD1 gene polymorphism, expression level and response to interferon beta in patients with multiple sclerosis
    Bahareh Khademi et al, 2021, Journal of Neuroimmunology CrossRef
  54. Role of Peripheral Immune Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
    Sarah Dhaiban et al, 2021, Sci CrossRef
  55. Adoptive transfer of immunomodulatory M2 macrophages suppresses experimental autoimmune encephalomyelitis in C57BL/6 mice via blockading NF‐κB pathway
    F. Chu et al, 2021, Clin Exp Immunol CrossRef
  56. Role of thyroid hormones in normal and abnormal central nervous system myelination in humans and rodents
    Maurice Pagnin et al, 2021, Frontiers in Neuroendocrinology CrossRef
  57. null
    Federica Cruciani et al, 2021 CrossRef
  58. Enantioselective Synthesis of Ozanimod, the Active Pharmaceutical Ingredient of a New Drug for Multiple Sclerosis
    Claudio Cianferotti et al, 2021, Eur. J. Org. Chem. CrossRef
  59. null
    Lorenza Brusini et al, 2021 CrossRef
  60. Gene expression profiles of YAP1, TAZ, CRB3, and VDR in familial and sporadic multiple sclerosis among an Iranian population
    Sheyda Khalilian et al, 2021, Sci Rep CrossRef
  61. Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?
    Shani Witman Tsur et al, 2021, IJMS CrossRef
  62. Clinical and Radiologic Disease Activity in Pregnancy and Postpartum in MS
    Annika Anderson et al, 2021, Neurol Neuroimmunol Neuroinflamm CrossRef
  63. Employing metabolomic approaches to determine the influence of age on experimental autoimmune encephalomyelitis (EAE)
    Soo Hyun Lee et al, 2021, Molecular Immunology CrossRef
  64. Perspective Insights and Application of Exosomes as a Novel Tool against Neurodegenerative Disorders: An Expository Appraisal
    Amey Kadbhane et al, 2021, Journal of Drug Delivery Science and Technology CrossRef
  65. null
    Polina Andropova et al, 2021 CrossRef
  66. Perspectives on urological care in multiple sclerosis patients
    Mohamad Moussa et al, 2021, IRDR CrossRef
  67. Explaining the facilitators of quality of life in patients with multiple sclerosis: a qualitative study
    Atefeh Homayuni et al, 2021, BMC Neurol CrossRef
  68. Impairment of Vestibulo-collic Reflex and Linear Vestibulo-ocular Reflex in Pediatric-onset Multiple Sclerosis Patients
    Gorkem Ertugrul et al, 2021, Clinical Neurophysiology CrossRef
  69. Evidence for Occupational Therapy Interventions Supporting Work and Social Participation for Adults With Multiple Sclerosis: A Systematic Review
    Julie Ann Nastasi et al, 2021, Am J Occup Ther CrossRef
  70. The Molecular Aspects of Disturbed Platelet Activation through ADP/P2Y12 Pathway in Multiple Sclerosis
    Angela Dziedzic et al, 2021, IJMS CrossRef
  71. Unraveling the MRI ‐Based Microstructural Signatures Behind Primary Progressive and Relapsing–Remitting Multiple Sclerosis Phenotypes
    Ilaria Boscolo Galazzo et al, 2021, J Magn Reson Imaging CrossRef
  72. Effects of Venlafaxine, Risperidone and Febuxostat on Cuprizone-Induced Demyelination, Behavioral Deficits and Oxidative Stress.
    George mihai Nitulescu, 0 CrossRef
  73. Oral Colonization by Candida Species in Patients with Multiple Sclerosis
    Eliana Tomomi Shimabukuro da Cunha et al, 2020, Mycopathologia CrossRef
  74. Modifying Diet and Exercise in MS (MoDEMS): Study design and protocol for a telehealth weight loss intervention for adults with obesity & Multiple Sclerosis
    Jared M. Bruce et al, 2021, Contemporary Clinical Trials CrossRef
  75. Experiences of healthcare for people living with multiple sclerosis and their healthcare professionals.
    Eluned Price et al, 2021, Health Expect CrossRef
  76. MRI but not Demographic or Clinical Characteristics Differ between Familial and Sporadic MS Cases
    Nahid Beladi Moghadam et al, 2021, Multiple Sclerosis and Related Disorders CrossRef
  77. MicroRNA-7188-5p and miR-7235 regulates Multiple sclerosis in an experimental mouse model
    Hairul-Islam Mohamed Ibrahim et al, 2021, Molecular Immunology CrossRef
  78. The IL-2 – IL-2 receptor pathway: Key to understanding multiple sclerosis
    Daphne Peerlings et al, 2021, Journal of Translational Autoimmunity CrossRef
  79. Potential Biomarkers Associated with Multiple Sclerosis Pathology
    Deepali Mathur et al, 2021, IJMS CrossRef
  80. Plasmalogens and Chronic Inflammatory Diseases
    José Carlos Bozelli et al, 2021, Front. Physiol. CrossRef
  81. Plasmalogen Replacement Therapy
    José Carlos Bozelli et al, 2021, Membranes CrossRef
  82. Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis
    Nicholas Dopkins et al, 2021, J Neuroimmune Pharmacol CrossRef
  83. Explaining stress coping behaviors in patients with multiple sclerosis based on the PRECEDE model: a qualitative directed content analysis
    Atefeh Homayuni et al, 2021, BMC Psychiatry CrossRef
  84. NAD+ improved experimental autoimmune encephalomyelitis by regulating SIRT1 to inhibit PI3K/Akt/mTOR signaling pathway
    Jinli Wang et al, 2021, Aging CrossRef
  85. Demonstration of Equivalence of Generic Glatiramer Acetate and Copaxone®
    Peter Lipsky et al, 2021, Front. Pharmacol. CrossRef
  86. Using Mnemonic in Management of Multiple Sclerosis
    Mohamed Toufic El Hussein et al, 2022 CrossRef
  87. Analysis of the Information Capacity of Neuronal Molecular Communications Under Demyelination and Remyelination
    Geoflly L. Adonias et al, 2021, IEEE Trans. Neural Syst. Rehabil. Eng. CrossRef
  88. Citrullination in the pathology of inflammatory and autoimmune disorders: recent advances and future perspectives
    Oskar Ciesielski et al, 2022, Cell. Mol. Life Sci. CrossRef
  89. Postoperative Outcomes Following Posterior Lumbar Fusion in Patients With Multiple Sclerosis
    Pramod N. Kamalapathy et al, 2022 CrossRef
  90. Single nucleotide variants around the connective tissue growth factor (CTGF/CCN2) gene and their association with multiple sclerosis risk, disability scores, and rate of disease progression
    Birsen Can Demirdöğen et al, 2022, Neurol Sci CrossRef
  91. Perceived stress in multiple sclerosis patients: Relationship with mood states and pain experience
    Mahmoud A. Khedr et al, 2022, Multiple Sclerosis and Related Disorders CrossRef
  92. Ofatumumab subcutaneous injection for the treatment of relapsing forms of multiple sclerosis
    G. Dalla Costa et al, 2022, Expert Review of Clinical Immunology CrossRef
  93. Personalized Nutritional Intervention to Improve Mediterranean Diet Adherence in Female Patients with Multiple Sclerosis: A Randomized Controlled Study
    Panos Papandreou et al, 2022, Dietetics CrossRef
  94. Pain Prevalence in Multiple Sclerosis in a Lisbon Tertiary Hospital: A Cross-Sectional Study
    Ana Filipa Junqueira et al, 2022 CrossRef
  95. A Quantitative Synthesis of Eight Decades of Global Multiple Sclerosis Research Using Bibliometrics
    Ismail Ibrahim Ismail et al, 2022, Front. Neurol. CrossRef
  96. In Vivo Assessment of the Ameliorative Impact of Some Medicinal Plant Extracts on Lipopolysaccharide-Induced Multiple Sclerosis in Wistar Rats
    Rabia Rasool et al, 2022, Molecules CrossRef
  97. Biochanin A Improves Memory Decline and Brain Pathology in Cuprizone-Induced Mouse Model of Multiple Sclerosis
    Rahaf Saeed Aldhahri et al, 2022, Behavioral Sciences CrossRef
  98. Mammalian target of rapamycin (mTOR) signaling pathway and traumatic brain injury: A novel insight into targeted therapy
    Ahmad Movahedpour et al, 2022, Cell Biochemistry & Function CrossRef
  99. Oligodendrocytes and myelin: Active players in neurodegenerative brains?
    Jing‐Fei Chen et al, 2022, Developmental Neurobiology CrossRef
  100. Modulating the Ubiquitin–Proteasome System: A Therapeutic Strategy for Autoimmune Diseases
    Dhananjay Yadav et al, 2022, Cells CrossRef
  101. Targeted Delivery Platforms for the Treatment of Multiple Sclerosis
    Zeinab Jan et al, 2022, Mol. Pharmaceutics CrossRef
  102. Current and Future Biomarkers in Multiple Sclerosis
    Jennifer Yang et al, 2022, IJMS CrossRef
  103. Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action
    Ana Muñoz-Jurado et al, 2022, Inflammopharmacol CrossRef
  104. Effectiveness of compassion-focused therapy on death anxiety and quality of life among women with multiple sclerosis
    Hamid Aboutalebi et al, 2022, MEDICAL SCIENCES CrossRef
  105. Innate Lymphoid Cells - Neglected Players in Multiple Sclerosis
    Negar Sadeghi Hassanabadi et al, 2022, Front. Immunol. CrossRef
  106. IL-10 Gene Polymorphisms and IL-10 Serum Levels in Patients with Multiple Sclerosis in Lithuania
    Ugne Masilionyte et al, 2022, Brain Sciences CrossRef
  107. Roles of Fatty Acids in Microglial Polarization: Evidence from In Vitro and In Vivo Studies on Neurodegenerative Diseases
    null Sanjay et al, 2022, IJMS CrossRef
  108. Bilateral coordination of gait at self-selected and fast speed in patients with multiple sclerosis: a case-control study.
    Luca Correale et al, 2022, Multiple Sclerosis and Related Disorders CrossRef
  109. Supporting the Role of Parenting for People With Multiple Sclerosis: A Guide for Clinicians
    John V. Rider et al, 2022, Archives of Physical Medicine and Rehabilitation CrossRef
  110. The effect of Urtica dioica extract on oxidative stress, heat shock proteins, and brain histopathology in multiple sclerosis model
    Fatemeh Namazi et al, 2022, Physiological Reports CrossRef
  111. Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration
    Ayaz M. Belkozhayev et al, 2022, CN CrossRef
  112. Case Report Multiple Sclerosis
    Ike Retno Yolanda et al, 2022, Open Access Maced J Med Sci CrossRef
  113. Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan–Kynurenine Metabolic System
    Masaru Tanaka et al, 2022, Cells CrossRef
  114. Treatment and Relapse Prevention of Typical and Atypical Optic Neuritis
    George Saitakis et al, 2022, IJMS CrossRef
  115. Palliative Care for Patients With Multiple Sclerosis
    Carolyn Ann Wilder, 2022, J Hosp Palliat Nurs CrossRef
  116. Experimental and Clinical Biomarkers for Progressive Evaluation of Neuropathology and Therapeutic Interventions for Acute and Chronic Neurological Disorders
    Doodipala Samba Reddy et al, 2022, IJMS CrossRef
  117. Posterior Tibial Nerve Stimulation as a neuromodulation therapy in Treatment of Neurogenic Overactive Bladder in Multiple Sclerosis: A prospective Randomized Controlled study
    Mohamed H. Marzouk et al, 2022, Multiple Sclerosis and Related Disorders CrossRef
  118. Reliability and validity of the Turkish version of speech pathology-specific questionnaire for persons with multiple sclerosis (SMS-TR)
    İbrahim Erensoy et al, 2022, International Journal of Speech-Language Pathology CrossRef
  119. Green Tea Catechins Attenuate Neurodegenerative Diseases and Cognitive Deficits
    Obaid Afzal et al, 2022, Molecules CrossRef
  120. Chronic Pain and Cannabidiol in Animal Models: Behavioral Pharmacology and Future Perspectives
    Gleice Kelli Silva-Cardoso et al, 2022, Cannabis and Cannabinoid Research CrossRef
  121. Plant based food bioactives: A boon or bane for neurological disorders
    Neeraj Choudhary et al, 2022, Critical Reviews in Food Science and Nutrition CrossRef
  122. RNA regulation of inflammatory responses in glia and its potential as a therapeutic target in central nervous system disorders
    Abhishek Guha et al, 2022, Glia CrossRef
  123. Neuroprotective effects of bornyl acetate on experimental autoimmune encephalomyelitis via anti-inflammatory effects and maintaining blood-brain-barrier integrity
    Joon-Il Lee et al, 2022, Phytomedicine CrossRef
  124. Supplementation with Crocus sativus L. (Saffron) against Placebo in Multiple Sclerosis: A Systematic Review and Synthesis without Meta-Analysis of Randomized Controlled Trials
    Maria G. Grammatikopoulou et al, 2022, Dietetics CrossRef
  125. Evaluation of in vivo lithium chloride effects as a GSK3-β inhibitor on human adipose derived stem cells differentiation into oligodendrocytes and re-myelination in an animal model of multiple sclerosis
    Sahar Ghosouri et al, 2022, Mol Biol Rep CrossRef
  126. The efficacy and safety of ginger supplementation in patients with multiple sclerosis: A rationale and study protocol for a double‐blind randomized controlled trial
    Sahar Foshati et al, 2023, Health Science Reports CrossRef
  127. Biomechanical changes of the common carotid artery and internal jugular vein in patients with multiple sclerosis
    Kimiya Rastegari et al, 2023, Ultrasonography CrossRef
  128. An Overview of the History, Pathophysiology, and Pharmacological Interventions of Multiple Sclerosis
    Ibrahim M Dighriri et al, 2023 CrossRef
  129. The quality of life in patients with multiple sclerosis – Association with depressive symptoms and physical disability: A prospective and observational study
    Aleksandra Kołtuniuk et al, 2023, Front. Psychol. CrossRef
  130. An intervention design for promoting quality of life among patients with multiple sclerosis: a protocol with a planning approach for a mixed methods study
    Atefeh Zahra HomayunHosseini, 2023, BMC Neurol CrossRef